Vlastimil Ščudla

Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial

Meletios Α. Dimopoulos, Francesca Gay, Fredrik Schjesvold et al. · The Lancet · 2018 · 231 citations · Full text

Regenerative Medicine, Cell Therapy, Transplantation +7

Complex karyotype and translocation t(4;14) define patients with high-risk newly diagnosed multiple myeloma: results of CMG2002 trial

Pavel Němec, Zuzana Zemanová, Petr Kuglík et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2011 · 40 citations

Subcutaneous Bortezomib in Multiple Myeloma Patients Induces Similar Therapeutic Response Rates as Intravenous Application But It Does Not Reduce the Incidence of Peripheral Neuropathy

Jiří Minařík, Petr Pavlíček, Luděk Pour et al. · PLoS ONE · 2015 · 37 citations · Full text

A Phase III Study Of ASCT Vs Cyclophosphamide-Lenalidomide-Dexamethasone and Lenalidomide-Prednisone Maintenance Vs Lenalidomide Alone In Newly Diagnosed Myeloma Patients

Antonio Palumbo, Francesca Gay, Andrew Spencer et al. · Blood · 2013 · 30 citations

High-dose chemotherapy followed by autologous stem cell transplantation changes prognosis of IgD multiple myeloma

Vladimír Maisnar, Roman Hájek, Vlastimil Ščudla et al. · Bone Marrow Transplantation · 2007 · 24 citations

Hematological Malignancy, Transplantation, Marrow Transplantation +9